• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年加拿大东部胃肠道癌症共识会议

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

机构信息

The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.

McGill University Health Centre, Montreal, QC H4A 3J1, Canada.

出版信息

Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185.

DOI:10.3390/curroncol28030185
PMID:34073199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8161825/
Abstract

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19-21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized and advanced anal cancer; watch and wait strategy for the management of rectal cancer; role of testing for dihydropyrimidine dehydrogenase (DPD) deficiency prior to commencement of fluoropyrimidine therapy; radiotherapy and systemic therapy in the adjuvant and unresectable settings for biliary tract cancer; and radiotherapy and systemic therapy in the perioperative setting for early-stage gastric cancer.

摘要

2019 年 9 月 19 日至 21 日,第 2019 届东加拿大胃肠癌共识会议在爱德华王子岛莫勒尔举行。参与胃肠道恶性肿瘤患者管理的医学肿瘤学、放射肿瘤学和外科肿瘤学专家参加了演讲和讨论会议,目的是制定这里提出的建议。本共识声明涉及肛门癌、结直肠癌、胆道癌和胃癌治疗的多个主题,包括:局部和晚期肛门癌的放疗和全身治疗;直肠癌的观察等待策略;氟嘧啶治疗前检测二氢嘧啶脱氢酶 (DPD) 缺乏症的作用;胆道癌辅助和不可切除治疗中的放疗和全身治疗;以及早期胃癌围手术期的放疗和全身治疗。

相似文献

1
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.2019 年加拿大东部胃肠道癌症共识会议
Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185.
2
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.2018年加拿大东部胃肠道癌共识会议
Curr Oncol. 2019 Oct;26(5):e665-e681. doi: 10.3747/co.26.5193. Epub 2019 Oct 1.
3
Eastern Canadian Colorectal Cancer Consensus Conference 2017.2017年加拿大东部结直肠癌共识会议
Curr Oncol. 2018 Aug;25(4):262-274. doi: 10.3747/co.25.4083. Epub 2018 Aug 14.
4
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.2016年加拿大东部胃肠道癌症共识会议
Curr Oncol. 2016 Dec;23(6):e605-e614. doi: 10.3747/co.23.3394. Epub 2016 Dec 21.
5
Report from the Western Canadian Gastrointestinal Consensus Cancer Conference-Management of Total Neoadjuvant Therapy in Rectal Cancer.加拿大西部胃肠道共识癌症会议报告-直肠癌新辅助放化疗的全程管理。
Curr Oncol. 2022 Feb 8;29(2):924-927. doi: 10.3390/curroncol29020078.
6
Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.第 20 届加拿大西部胃肠癌症共识会议报告;萨斯卡通,萨斯喀彻温省;2018 年 9 月 28 日至 29 日。
Curr Oncol. 2019 Dec;26(6):e773-e784. doi: 10.3747/co.26.5517. Epub 2019 Dec 1.
7
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023.2023 年加拿大东部胃肠道癌症共识会议。
Curr Oncol. 2023 Sep 4;30(9):8172-8185. doi: 10.3390/curroncol30090593.
8
Report from the 21st Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; 20-21 September 2019.第 21 届加拿大西部胃肠道癌症共识会议报告;艾伯塔省卡尔加里;2019 年 9 月 20-21 日。
Curr Oncol. 2021 Sep 21;28(5):3629-3648. doi: 10.3390/curroncol28050310.
9
Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022.第 24 届加拿大西部胃肠道癌症共识会议关于结直肠癌的年度报告,2022 年 10 月 28-29 日,不列颠哥伦比亚省里士满。
Curr Oncol. 2023 Aug 29;30(9):7964-7983. doi: 10.3390/curroncol30090579.
10
Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.第19届加拿大西部胃肠癌共识会议报告;马尼托巴省温尼伯;2017年9月29日至30日。
Curr Oncol. 2018 Aug;25(4):275-284. doi: 10.3747/co.25.4109. Epub 2018 Aug 14.

引用本文的文献

1
The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer.2019年冠状病毒病对胃癌患者相关护理质量的影响。
Middle East J Dig Dis. 2024 Jan;16(1):12-22. doi: 10.34172/mejdd.2024.363. Epub 2024 Jan 31.
2
A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer.无法切除的晚期或转移性胆道癌的真实世界治疗模式和结局的系统文献回顾
Target Oncol. 2023 Nov;18(6):837-852. doi: 10.1007/s11523-023-01000-5. Epub 2023 Sep 26.

本文引用的文献

1
Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?肛管I期鳞状细胞癌:单纯放射治疗是否足以治愈?
Cancers (Basel). 2020 Nov 4;12(11):3248. doi: 10.3390/cancers12113248.
2
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.国际罕见癌症倡议多中心随机二期试验:顺铂和氟尿嘧啶对比卡铂和紫杉醇治疗晚期肛门癌:InterAAct。
J Clin Oncol. 2020 Aug 1;38(22):2510-2518. doi: 10.1200/JCO.19.03266. Epub 2020 Jun 12.
3
Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.分析癌症患者放化疗后最佳随访时间的研究
Am J Clin Oncol. 2020 May;43(5):319-324. doi: 10.1097/COC.0000000000000673.
4
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.胃癌中微卫星不稳定性作为生物标志物价值的个体化患者数据汇总分析。
J Clin Oncol. 2019 Dec 10;37(35):3392-3400. doi: 10.1200/JCO.19.01124. Epub 2019 Sep 12.
5
Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma.早期(T1-T2N0)肛管鳞状细胞癌同步放化疗与单纯放疗相比的生存获益及使用同步放化疗的预测因素。
J Gastrointest Oncol. 2019 Aug;10(4):616-622. doi: 10.21037/jgo.2019.02.06.
6
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗(FLOT4):一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
7
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌(BILCAP):一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
8
Nonsurgical Management of Rectal Cancer.直肠癌的非手术治疗。
J Oncol Pract. 2019 Mar;15(3):123-131. doi: 10.1200/JOP.18.00769.
9
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.立体定向体放射治疗剂量及其对局部晚期肝内和肝外胆管癌患者局部控制和总生存的影响。
Radiother Oncol. 2019 Mar;132:42-47. doi: 10.1016/j.radonc.2018.11.015. Epub 2018 Dec 20.
10
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.吉西他滨和奥沙利铂化疗或监测在切除的胆管癌 (PRODIGE 12-ACCORD 18-UNICANCER GI):一项随机 III 期研究。
J Clin Oncol. 2019 Mar 10;37(8):658-667. doi: 10.1200/JCO.18.00050. Epub 2019 Feb 1.